From July 14, 2022 to September 30, 2022, the company has repurchased 6,658,500 shares, representing 1.18% for CNY 34.95 million. With this, the company has completed the repurchase of 6,658,500 shares, representing 1.18% for CNY 34.95 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.34 CNY | +0.46% |
|
+2.84% | -29.20% |
1st Jan change | Capi. | |
---|---|---|
-29.20% | 332M | |
+62.89% | 841B | |
+40.42% | 625B | |
-4.06% | 360B | |
+17.57% | 327B | |
+9.92% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+15.14% | 174B | |
+0.85% | 162B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.